SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum
GLD 379.87+0.4%Nov 11 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
carranza2
ggersh
maceng2
To: carranza2 who wrote (182348)1/6/2022 2:44:46 PM
From: jpdunwell3 Recommendations  Read Replies (1) of 217706
 
Well, since you asked for it, here's another study from Canada showing the same results (which cites the Denmark study, and a UK study as well):

medrxiv.org



“In the Danish study, there was no significant protection against Omicron infection beyond 31

days after the second dose of BNT162b2, with significant negative VE estimates 91-150 days after the

second dose. We also observed a pattern of non-existent, or even negative VE in Ontario. However, VE

in Denmark (available for BNT162b2 only) recovered to 55% in the first 30 days following a third

dose. The Danish estimates are also aligned with other study results from England,11 where an

estimated VE of 0-20% against symptomatic infection was observed for those with 2 doses of

BNT162b2 and 55-80% for those with 3 doses, and from Scotland,18 where relative VE against

Omicron following a third dose was estimated at 56-57% in the 2 weeks following a third dose

compared to those who had received 2 vaccine doses =25 weeks before the symptom onset date.

Finally, a study from South Africa estimated VE against infection at 33% in the Omicron period

compared to 77% in the pre-Omicron period.19”

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News